Filed In:
Vimovo (Naproxen/Esomeprazole)
Vimovo was approved by the U.S. Food and Drug Administration (FDA) for relief of the signs and symptoms of osteoarthritis, rheumatoid arthritis, ankylosing spondylitis, and to decrease the risk of developing gastric ulcers in patients at risk of developing NSAID associated gastric ulcers.
Vimovo - What You Should Know
Vimovo, a combination of naproxen and immediate-release esomeprazole, is approved for several types of arthritis.
Vimovo Approved by FDA to Treat Arthritis
Vimovo is a combination of naproxen and immediate-release esomeprazole. The immediate release formulation allows for sequential release of the active components, with esomeprazole delivered in advance of the release of the naproxen.
NSAIDs - 10 Things You Should Know
NSAIDs (nonsteroidal anti-inflammatory drugs) have been used to treat arthritis for years. NSAIDs have anti-inflammatory, analgesic (painkilling), and anti-pyretic (fever-reducing) properties.
Gastrointestinal Bleeding - Don't Ignore Your Symptoms
Gastrointestinal bleeding refers to any bleeding that occurs in the gastrointestinal tract, which runs from your mouth to your anus. More specifically, the gastrointestinal tract is divided into the upper gastrointestinal tract and the lower gastrointestinal tract.
9 Ways to Reduce Your Risk of Bleeding Ulcers from NSAID Use
Bleeding ulcers are one of the most serious problems associated with NSAID (nonsteroidal anti-inflammatory) use. While there are many potential side effects that can occur from longterm use of NSAIDs, bleeding ulcers can be life-threatening and must be taken seriously.
Vimovo Information
Information about Vimovo from drugmaker AstraZeneca.
How Vimovo Works
Vimovo combines naproxen with a proton pump inhibitor. See how Vimovo works for arthritis patients.
Vimovo Prescribing Information
Learn about the approved use of Vimovo, as well as safety information.
